Lv1
40 积分 2026-06-15 加入
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
2天前
已完结
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial
1个月前
已完结
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab
1个月前
已完结
皖公网安备34019202002308
